Chemotherapy Trials in Beijing, China
Conditions / Chemotherapy / Beijing, China
Clinical trials for Chemotherapy investigate a range of treatment strategies and patient populations.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03778541 | HFSRT With Concurrent TMZ for Large BMs | UNKNOWN | PHASE3 |
| NCT00525642 | Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer | UNKNOWN | PHASE2/PHASE3 |
| NCT06168032 | COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research | RECRUITING | NA |
| NCT06429839 | Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients | RECRUITING | PHASE2 |
| NCT06864533 | Adjuvant Chemotherapy for High Malignant Prostate Cancer | RECRUITING | NA |
| NCT06202781 | Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy | UNKNOWN | — |
| NCT02301481 | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma | COMPLETED | PHASE2 |
| NCT06768307 | Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer | NOT_YET_RECRUITING | PHASE2 |
| NCT00503386 | Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting | COMPLETED | PHASE2 |
| NCT06410651 | Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma | RECRUITING | PHASE2 |